Robin Lewis Jones, Neeta Somaiah, Sebastian Bauer, Michael C. Heinrich, Jonathan C. Trent, Cesar Serrano, Hidekazu Hirano, Saori Mishima, Lin Shen, Min-Hee Ryu, Margaret von Mehren, Patrick Schöffski, Jean-Yves Blay, Ciara M. Kelly, George Demetri, Peter Reichardt, Salem Rustom, Hank Schmidt, Sean O’Donnell, Suzanne George. "Velzatinib (IDRX-42) as 1L or 2L therapy for advanced gastrointestinal stromal tumors (GISTs) by KIT mutation status: A subset analysis of the phase 1/1b StrateGIST 1 study.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.11501